ISZO CAPITAL MANAGEMENT LP - Q4 2022 holdings

Add to watchlist

$7.48 Million is the total value of ISZO CAPITAL MANAGEMENT LP's 7 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 50.0% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
LNDC SellLIFECORE BIOMEDICAL INC$2,422,081
-82.2%
373,778
-75.6%
32.38%
+38.8%
SellCBL & ASSOC PPTYS INC$1,807,533
-46.7%
78,316
-40.8%
24.16%
+315.8%
LNTH SellLANTHEUS HLDGS INC$870,244
-90.9%
17,077
-87.5%
11.63%
-29.2%
CO  GLOBAL CORD BLOOD CORPORATIO$835,690
-0.0%
279,4950.0%11.17%
+679.1%
CCEL SellCRYO-CELL INTL INC$824,981
-51.5%
195,031
-30.1%
11.03%
+278.1%
CVNA NewCARVANA COcl a$711,000–150,000
+100.0%
9.50%–
AMPY NewAMPLIFY ENERGY CORP NEW$8,377–953
+100.0%
0.11%–
NTP ExitNAM TAI PPTY INC$0–-6,918,372
-100.0%
-50.07%–
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NAM TAI PPTY INC16Q3 202260.5%
AVID BIOSERVICES INC13Q4 202146.6%
XPEL INC10Q4 202122.3%
TARO PHARMACEUTICALS INDUS LTD8Q4 201585.7%
AMERCO8Q4 201511.2%
NATHANS FAMOUS INC NEW7Q1 201768.9%
MMA CAP MGMT LLC7Q1 201717.8%
CBL & ASSOC PPTYS INC6Q3 202395.2%
LIFECORE BIOMEDICAL INC6Q4 202235.1%
CRYO-CELL INTL INC6Q4 202211.0%

View ISZO CAPITAL MANAGEMENT LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-12

View ISZO CAPITAL MANAGEMENT LP's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (7479907.0 != 7479906.0)

Export ISZO CAPITAL MANAGEMENT LP's holdings

CSVXLS